Episode #28
The Chiro-Factor Episode 28: Ozempic Deception: What Chiropractors Need to Know About GLP-1 Drugs
In this episode of The Chiro-Factor Podcast, Dr. Brad Glowaki and Dr. James Chestnut go deep on two fronts: how to build adjustment-centric, evidence-based practices that patients trust — and a hard-hitting science breakdown of the GLP-1 (Ozempic) phenomenon sweeping global healthcare.Glow shares takeaways from his recent Australia workshops, and the duo unpacks the Therapeutic Working Alliance, the relationship Report of Findings, and why a segmentally specific adjustment to a subluxated segment has measurably greater neurological impact than adjusting one that's already moving. Then Chestnut turns "off the leash" on the GLP-1 industry — the staggering costs, the muscle wasting, the anhedonia, the rebound weight gain, and why lifestyle change remains the only real solution.Whether you catch this in one sitting or split it across your commute, it's packed with science, sound bites, and practice wisdom.🎯 Grab your seats to the Best Practices Seminar here: https://www.levelupmentoring.rocks/bestpracticesEpisode Timestamps:00:00 — Intro & where to find the podcast and Best Practices seminars01:30 — Australia recap & the mission behind the podcast04:30 — Why there'll never be a double-blind study on the adjustment; defusing the "subluxation" debate07:11 — The Niazi (2025) study: specific adjustments and the sensory motor cortex08:59 — Why a subluxation is physiologically detrimental — and the adjustment restores it11:37 — Loading value on Day One & the Chestnut Spinal Health Assessment13:40 — The Therapeutic Working Alliance: goal, intervention & bond agreement16:24 — The power of "because" in the Report of Findings19:01 — Building the bond of trust; why patients need more care than you think22:43 — The law of averages: do fewer, more valid tests25:04 — Practice announcements, the "if" statement & no answers on Day One33:43 — Shifting gears: GLP-1s and Ozempic — the setup35:18 — The numbers: 100 million obese adults, $70 billion a year, trillions projected39:25 — Using AI to check the evidence; lifestyle vs. drugs41:12 — Insurance profits, lobbying & the Medicare/Medicaid "guaranteed lottery ticket"44:16 — Side effects: blindness, "ass wasting," thyroid cancer & the denial playbook45:42 — The obesity pandemic: from "obesity gene" to body positivity to the drug rollout48:08 — Big Tobacco → Big Food → Big Ag → Big Pharma: the same playbook50:47 — GLP-1s now approved for children54:28 — How GLP-1s actually work: the peptide, the vagus nerve & satiation1:08:37 — Side effects explained: nausea, anhedonia, lost motivation & muscle/bone loss1:15:18 — Why people start anyway; the 70–80% who quit and the near-100% rebound1:20:05 — The reframe: injecting = admitting you've lost control1:23:04 — How we got 100 million obese adults: policy, lobbying & the SAD diet1:25:33 — "The ship isn't sinking — they're sinking our ship"; cutting off demand1:29:12 — Peptides teaser & upcoming Aaron Siri episode1:34:52 — Cost-benefit of injectables; living a reasonable life1:38:30 — Recap of the Ozempic numbers for part-two listeners1:40:07 — Reframing "health": the lowered number vs. true function1:57:30 — "You won the lottery": the next generation of chiropractors2:00:42 — Final thoughts, coaching, the ethical millionaire & sign-off
